{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-030491","form_type":"8-K","ticker":"AMRX","cik":"0001723128","company_name":"Amneal Pharmaceuticals, Inc.","filed_at":"2026-07-31T20:08:50+00:00","discovered_at":"2026-07-31T20:10:00.524386+00:00","generated_at":"2026-07-31T20:10:16.644687+00:00","sec_items":["5.07"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Amneal shareholders approve acquisition of Kashiv BioSciences; closing expected H2 2026","bullets":["Stockholders approved Purchase Agreement to acquire 100% of Kashiv BioSciences membership interests.","Approved issuance of 28,942,108 shares of Class A common stock to Sellers in connection with the deal.","Vote results: Transaction Proposal 138,265,079 for, 655,759 against, 67,147 abstain; Stock Issuance Proposal 286,714,072 for, 1,791,016 against, 62,071 abstain.","Closing expected in second half of 2026, subject to remaining conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-030491","json":"https://secwatch.observer/filing/0001140361-26-030491.json","markdown":"https://secwatch.observer/filing/0001140361-26-030491.md","text":"https://secwatch.observer/filing/0001140361-26-030491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1723128/000114036126030491/0001140361-26-030491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1723128/000114036126030491/ef20079129_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-31T20:10:16.644687+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}